A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)
PHASE3
Himalayas-1 is a randomized, open-label, global, multicenter phase 3 study ...
Status
Recruiting
Location
Urology Specialists of the Carolinas - University Place
A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1).
PHASE3
Pfizer MEVPRO-1 (C2321014) is a randomized, open-label, multi-center clinic...
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
PHASE3
This study will explore whether a combination of the investigational drug m...